A company that indexes journals — which, in turn, designates their impact factors — has delisted Oncotarget, a cancer journal that was recently removed from MEDLINE. Just three months ago, on October 18, the indexing company Clarivate Analytics (formerly part of Thomson Reuters) named Oncotarget a “rising star” in the field of molecular biology and genetics. […]

The post Indexing company praises cancer journal, then kicks it out appeared first on Retraction Watch.